Menopausia y Terapia Hormonal de la Menopausia Las recomendaciones 2018 de la Unidad de Endocrinología Ginecológica de Clínica Alemana de Santiago -Sociedad Italiana de la Menopausia y la Sociedad Chilena de Endocrinología Ginecológica
2018; Sociedad Chilena de Obstetricia y Ginecología; Volume: 83; Issue: 5 Linguagem: Inglês
10.4067/s0717-75262018000500527
ISSN0717-7526
AutoresM. Parra, N. Lagos, Marco Levancini, M. Villarroel, E. Pizarro, Paula Sofía Vanhauwaert, Soledad Velasco, M Fernadez, Marco Gambacciani, Nicoletta Biglia, Angelo Cagnacci, Salvatore Caruso, Ettore Cicinelli, Vincenzo De Leo, Costantino Di Carlo, Manuela Farris, Alessandro Gambera, Secondo Guaschino, Antonio Lanzone, Paoletti Am, Novella Russo, Franco Vicariotto, Paola Villa, Annibale Volpe, Pablo Lavín, M. Lopez, Claudia Campusano, Patricio Barriga, Sergio Brantes G.,
Tópico(s)Women's cancer prevention and management
ResumoIn the last decade, the risk benefits ratio of MHT has been evaluated mainly in terms of cardiovascular risk. Present Consensus Statement is largely inspired by the Global Consensus on Menopausal Hormone Therapy in 2013 and 2016 by leading global menopause societies (The American Society for Reproductive Medicine, The Asia Pacific Menopause Federation, The Endocrine Society, The European Menopause and Andropause Society, The International Menopause Society, The International Osteoporosis Foundation and The North American Menopause Society).
Referência(s)